Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 2161376, 7 pages
http://dx.doi.org/10.1155/2016/2161376
Research Article

Renin-Angiotensin System Gene Variants and Type 2 Diabetes Mellitus: Influence of Angiotensinogen

1Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2School of Pharmaceutical Sciences, University Sains Malaysia, 11800 Penang, Malaysia

Received 17 November 2014; Revised 24 April 2015; Accepted 11 May 2015

Academic Editor: Aziz Ghahary

Copyright © 2016 Siew Mei Joyce-Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Fowler, “Microvascular and macrovascular complications of diabetes,” Clinical Diabetes, vol. 26, no. 2, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. W. T. Cade, “Diabetes-related microvascular and macrovascular diseases in the physical therapy setting,” Physical Therapy, vol. 88, no. 11, pp. 1322–1335, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. D. R. Whiting, L. Guariguata, C. Weil, and J. Shaw, “IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030,” Diabetes Research and Clinical Practice, vol. 94, no. 3, pp. 311–321, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Doria, M.-E. Patti, and C. R. Kahn, “The emerging genetic architecture of type 2 diabetes,” Cell Metabolism, vol. 8, no. 3, pp. 186–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Sladek, G. Rocheleau, J. Rung et al., “A genome-wide association study identifies novel risk loci for type 2 diabetes,” Nature, vol. 445, no. 7130, pp. 881–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. L. A. Velloso, F. Folli, X. J. Sun, M. F. White, M. J. A. Saad, and C. R. Kahn, “Cross-talk between the insulin and angiotensin signaling systems,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 22, pp. 12490–12495, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. A. J. Scheen, “Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system,” Drugs, vol. 64, no. 22, pp. 2537–2565, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Wangkumhang, P. J. Shaw, K. Chaichoompu et al., “Insight into the peopling of Mainland Southeast Asia from Thai population genetic structure,” PLoS ONE, vol. 8, no. 11, Article ID e79522, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Wei, S. P. Gaskill, S. M. Haffner, and M. P. Stern, “Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans—a 7-year prospective study,” Obesity Research, vol. 5, no. 1, pp. 16–23, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. Q. Qiao, G. Hu, J. Tuomilehto et al., “Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts,” Diabetes Care, vol. 26, no. 6, pp. 1770–1780, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Logue, J. J. Walker, H. M. Colhoun et al., “Do men develop type 2 diabetes at lower body mass indices than women?” Diabetologia, vol. 54, no. 12, pp. 3003–3006, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Schienkiewitz, M. B. Schulze, K. Hoffmann, A. Kroke, and H. Boeing, “Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study,” The American Journal of Clinical Nutrition, vol. 84, no. 2, pp. 427–433, 2006. View at Google Scholar · View at Scopus
  13. M. A. Eberle, P. C. Ng, K. Kuhn et al., “Power to detect risk alleles using genome-wide tag SNP panels,” PLoS Genetics, vol. 3, no. 10, Article ID e170, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Mtiraoui, I. Ezzidi, A. Turki, M. Chaieb, T. Mahjoub, and W. Y. Almawi, “Renin-angiotensin-aldosterone system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients,” Journal of the Renin Angiotensin Aldosterone System, vol. 12, no. 4, pp. 572–580, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Shaikh, S. M. Shahid, Q. Mansoor, M. Ismail, and A. Azhar, “Genetic variants of ACE (insertion/deletion) and AGT (M268T) genes in patients with diabetes and nephropathy,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 15, no. 2, pp. 124–130, 2014. View at Publisher · View at Google Scholar
  16. J.-K. Yang, J.-B. Zhou, Z. Xin et al., “Interactions among related genes of renin-angiotensin system associated with type 2 diabetes,” Diabetes Care, vol. 33, no. 10, pp. 2271–2273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Ichikawa, T. Konoshita, T. Nakaya et al., “Genetic variant of the renin-angiotensin system and prevalence of type 2 diabetes mellitus: a modest but significant effect of aldosterone synthase,” Acta Diabetologica, vol. 51, no. 4, pp. 595–599, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Ramachandran, C. Snehalatha, A. S. Shetty, and A. Nanditha, “Trends in prevalence of diabetes in Asian countries,” World Journal of Diabetes, vol. 3, no. 6, pp. 110–117, 2012. View at Publisher · View at Google Scholar
  19. S. R. Lee, J. Y. Moon, S. H. Lee et al., “Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects,” Kidney and Blood Pressure Research, vol. 37, no. 2-3, pp. 95–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. D. Zhou, R. Ruiter, J. Zhang et al., “Angiotensin-converting enzyme I/D polymorphism is not associated with type 2 diabetes in a Chinese population,” Journal of the Renin-Angiotensin-Aldosterone System, vol. 13, no. 3, pp. 372–378, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. V. van Harmelen, M. Elizalde, P. Ariapart et al., “The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity,” International Journal of Obesity, vol. 24, no. 6, pp. 673–678, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Nakajima, L. B. Jorde, T. Ishigami et al., “Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations,” The American Journal of Human Genetics, vol. 70, no. 1, pp. 108–123, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. X. Jeunemaitre, F. Soubrier, Y. V. Kotelevtsev et al., “Molecular basis of human hypertension: role of angiotensinogen,” Cell, vol. 71, no. 1, pp. 169–180, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Inoue, T. Nakajima, C. S. Williams et al., “A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro,” The Journal of Clinical Investigation, vol. 99, no. 7, pp. 1786–1797, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Ogihara, T. Asano, K. Ando et al., “Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling,” Hypertension, vol. 40, no. 6, pp. 872–879, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. J. C. N. Chan, V. Malik, W. Jia et al., “Diabetes in Asia: epidemiology, risk factors, and pathophysiology,” The Journal of the American Medical Association, vol. 301, no. 20, pp. 2129–2140, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. D. Sniderman, R. Bhopal, D. Prabhakaran, N. Sarrafzadegan, and A. Tchernof, “Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis,” International Journal of Epidemiology, vol. 36, no. 1, pp. 220–225, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. K.-H. Yoon, J.-H. Lee, J.-W. Kim et al., “Epidemic obesity and type 2 diabetes in Asia,” The Lancet, vol. 368, no. 9548, pp. 1681–1688, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. M. C. Cornelis and F. B. Hu, “Gene-environment interactions in the development of type 2 diabetes: recent progress and continuing challenges,” Annual Review of Nutrition, vol. 32, pp. 245–259, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Amos, E. Driscoll, and J. I. Hoffman, “Candidate genes versus genome-wide associations: which are better for detecting genetic susceptibility to infectious disease?” Proceedings of the Royal Society B: Biological Sciences, vol. 278, no. 1709, pp. 1183–1188, 2011. View at Publisher · View at Google Scholar · View at Scopus